← Back to headlines
Analysts Bullish on Pfizer's Q1 Outlook and Robust Pipeline
Ahead of its Q1 earnings, analysts are expressing optimism about Pfizer's strong drug pipeline, with particular focus on its obesity pipeline and upcoming guidance.
4 May, 14:56 — 4 May, 14:56
Sources
Showing 1 of 1 sources
